Markers of keratinocyte differentiation in snuff-induced leukoplakia.
Biopsy specimens from 12 patients who used snuff and had leukoplakia in the mucosa of the oral cavity were studied and compared with specimens from their own nonleukoplakic oral mucosa, as well as with biopsy specimens from corresponding areas of the oral cavity in 12 nonsmoking, nontobacco-using control subjects. The biopsy specimens were processed using standard immunohistochemical rabbit antibody to human involucrin and mouse antibody to human transglutaminase type I as the primary antibodies. A computer-driven light absorbance image analysis system was used to determine the optical density of each of the marker-stained specimens. Optical density measurements were compared using a one-way analysis of variance. The expression of involucrin was significantly higher in the epithelium of the nonsmoking, nontobacco-using control subjects (0.2937 +/- 0.0725 optical density) in comparison with the normal-appearing mucosa (0.2283 +/- 0.0488 optical density) and the leukoplakic mucosa of the snuff-using patients (0.2007 +/- 0.0669 optical density) (p < 0.05). The expression of transglutaminase type I was also significantly higher in the epithelium of the nonsmoking, nontobacco-using controls (0.2308 +/- 0.1381 optical density) than in the patients with leukoplakic mucosa (0.1310 +/- 0.0472 optical density) (p < 0.05). However, there was no difference when compared with the normal-appearing mucosa of the patients in the snuff-using group (0.1686 +/- 0.0323 optical density). This study has shown that involucrin and transglutaminase type I are expressed differently in leukoplakic oral mucosa of snuff users and in normal oral mucosa and that this difference can be measured objectively.
Department of Otorhinolaryngology, University of Oklahoma Health Sciences Center, Oklahoma City 73190-3048.
J M
JM
Gilchrist
G C
GC
Thompson
J E
JE
Medina
D000328:Adult; D015415:Biomarkers / Q000032:analysis; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D006801:Humans; D015603:Keratinocytes / Q000166:cytology / Q000378:metabolism* / Q000473:pathology*; D007972:Leukoplakia, Oral / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000166:cytology / Q000378:metabolism* / Q000473:pathology*; D010947:Plants, Toxic; D011498:Protein Precursors / Q000378:metabolism*; D014030:Tobacco, Smokeless / Q000009:adverse effects; D011503:Transglutaminases / Q000378:metabolism*
D015415:Biomarkers; D011498:Protein Precursors; C032253:involucrin; D011503:Transglutaminases